← BioTransfer GEO Dataset Finder
GEO series

Pre-clinical optimization of MDM2 antagonist treatment of glioblastoma

GSE291870 Homo sapiens Expression profiling by high throughput sequencing 47 samples 2026/03/31 GPL24676
Summary
In glioblastomas wildtype p53 is inhibited by MDM2 or MDM4 amplification, or deletion of CDKN2A (coding for MDM2 inhibitor p14ARF). MDM2 pharmacological antagonists (MDM2a) are currently in clinical trials for wt p53 glioblastoma. Here we test the hypotheses that GBM response to MDM2a will vary, and that transcriptional activation signatures in response to MDM2a will have predictive value and support the identification of mechanisms of resistance.
Download
NCBI GEO page ↗ {# Names what the click gives you. "Open in finder" meant nothing to a visitor who arrived from a search engine and has never seen the tool. #} Find more human RNA-seq datasets →
Similar datasets

Search all human RNA-seq datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.